The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The RaPID Platform for the Discovery of Pseudo-Natural Macrocyclic Peptides
Open accessAbstract
ConspectusAlthough macrocyclic peptides bearing exotic building blocks have proven their utility as pharmaceuticals, the sources of macrocyclic peptide drugs have been largely limited to mimetics of native peptides or natural product peptides. However, the recent emergence of technologies for discovering de novo bioactive peptides has led to their reconceptualization as a promising therapeutic modality. For the construction and screening of libraries of such macrocyclic peptides, our group has devised a platform to conduct affinity-based selection of massive libraries (>1012 unique sequences) of in vitro expressed macrocyclic peptides, which is referred to as the random nonstandard peptides integrated discovery (RaPID) system. The RaPID system integrates genetic code reprogramming using the FIT (flexible in vitro translation) system, which is largely facilitated by flexizymes (flexible tRNA-aminoacylating ribozymes), with mRNA display technology.We have demonstrated that the RaPID system enables rapid discovery of various de novo pseudo-natural peptide ligands for protein targets of interest. Many examples discussed in this Account prove that thioether-closed macrocyclic peptides (teMPs) obtained by the RaPID system generally exhibit remarkably high affinity and specificity, thereby potently inhibiting or activating a specific function(s) of the target. Moreover, such teMPs are used for a wide range of biochemical applications, for example, as crystallization chaperones for intractable transmembrane proteins and for in vivo recognition of specific cell types. Furthermore, recent studies demonstrate that some teMPs exhibit pharmacological activities in animal models and that even intracellular proteins can be inhibited by teMPs, illustrating the potential of this class of peptides as drug leads.Besides the ring-closing thioether linkage in the teMPs, genetic code reprogramming by the FIT system allows for incorporation of a variety of other exotic building blocks. For instance, diverse nonproteinogenic amino acids, hydroxy acids (ester linkage), amino carbothioic acid (thioamide linkage), and abiotic foldamer units have been successfully incorporated into ribosomally synthesized peptides. Despite such enormous successes in the conventional FIT system, multiple or consecutive incorporation of highly exotic amino acids, such as d- and β-amino acids, is yet challenging, and particularly the synthesis of peptides bearing non-carbonyl backbone structures remains a demanding task. To upgrade the RaPID system to the next generation, we have engaged in intensive manipulation of the FIT system to expand the structural diversity of peptides accessible by our in vitro biosynthesis strategy. Semilogical engineering of tRNA body sequences led to a new suppressor tRNA (tRNAPro1E2) capable of effectively recruiting translation factors, particularly EF-Tu and EF-P. The use of tRNAPro1E2 in the FIT system allows for not only single but also consecutive and multiple elongation of exotic amino acids, such as d-, β-, and γ-amino acids as well as aminobenzoic acids. Moreover, the integration of the FIT system with various chemical or enzymatic posttranslational modifications enables us to expand the range of accessible backbone structures to non-carbonyl moieties prominent in natural products and peptidomimetics. In such systems, FIT-expressed peptides undergo multistep backbone conversions in a one-pot manner to yield designer peptides composed of modified backbones such as azolines, azoles, and ring-closing pyridines. Our current research endeavors focus on applying such in vitro biosynthesis systems for the discovery of bioactive de novo pseudo-natural products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
RNA-peptide fusions for the in vitro selection of peptides and proteins
Roberts, R. W., & Szostak, J. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12297 · Cited by 1,105
New developments in RiPP discovery, enzymology and engineering
Montalbán-López, M., Scott, T. A., Ramesh, S., Rahman, I. R., van Heel, A. J., Viel, J. H., Bandarian, V., Dittmann, E., Genilloud, O., Goto, Y., et al. (2021) · Natural Product Reports · doi:10.1039/d0np00027b · Cited by 787
Self-citationSchmidt, E. W., Nelson, J. T., Rasko, D. A., Sudek, S., Eisen, J. A., Haygood, M. G., & Ravel, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501424102 · Cited by 567
Macrocycles: lessons from the distant past, recent developments, and future directions
Yudin, A. K. (2015) · Chemical Science · doi:10.1039/c4sc03089c · Cited by 493
EF-P Is Essential for Rapid Synthesis of Proteins Containing Consecutive Proline Residues
Doerfel, L. K., Wohlgemuth, I., Kothe, C., Peske, F., Urlaub, H., & Rodnina, M. V. (2013) · Science · doi:10.1126/science.1229017 · Cited by 489
Flexizymes for genetic code reprogramming
Goto, Y., Katoh, T., & Suga, H. (2011) · Nature Protocols · doi:10.1038/nprot.2011.331 · Cited by 472
Self-citationA highly flexible tRNA acylation method for non-natural polypeptide synthesis
Murakami, H., Ohta, A., Ashigai, H., & Suga, H. (2006) · Nature Methods · doi:10.1038/nmeth877 · Cited by 468
Self-citationTranslation Elongation Factor EF-P Alleviates Ribosome Stalling at Polyproline Stretches
Ude, S., Lassak, J., Starosta, A. L., Kraxenberger, T., Wilson, D. N., & Jung, K. (2013) · Science · doi:10.1126/science.1228985 · Cited by 463
Nonproteinogenic Amino Acid Building Blocks for Nonribosomal Peptide and Hybrid Polyketide Scaffolds
Walsh, C. T., O'Brien, R. V., & Khosla, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208344 · Cited by 406
Neri, D., & Lerner, R. A. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012550 · Cited by 364
Yamagishi, Y., Shoji, I., Miyagawa, S., Kawakami, T., Katoh, T., Goto, Y., & Suga, H. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.09.013 · Cited by 346
Self-citationUniform Binding of Aminoacyl-tRNAs to Elongation Factor Tu by Thermodynamic Compensation
LaRiviere, F. J., Wolfson, A. D., & Uhlenbeck, O. C. (2001) · Science · doi:10.1126/science.1064242 · Cited by 330
Reprogramming the Translation Initiation for the Synthesis of Physiologically Stable Cyclic Peptides
Goto, Y., Ohta, A., Sako, Y., Yamagishi, Y., Murakami, H., & Suga, H. (2008) · ACS Chemical Biology · doi:10.1021/cb700233t · Cited by 275
Self-citationStructural basis for the drug extrusion mechanism by a MATE multidrug transporter
Tanaka, Y., Hipolito, C. J., Maturana, A. D., Ito, K., Kuroda, T., Higuchi, T., Katoh, T., Kato, H. E., Hattori, M., Kumazaki, K., et al. (2013) · Nature · doi:10.1038/nature12014 · Cited by 250
Self-citationSelection-Based Discovery of Druglike Macrocyclic Peptides
Passioura, T., Katoh, T., Goto, Y., & Suga, H. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035456 · Cited by 222
Self-citationDesigning Helical Molecular Capsules Based on Folded Aromatic Amide Oligomers
Ferrand, Y., & Huc, I. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00075 · Cited by 212
Constrained peptides' time to shine?
Morrison, C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.125 · Cited by 198
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
Kawamura, A., Münzel, M., Kojima, T., Yapp, C., Bhushan, B., Goto, Y., Tumber, A., Katoh, T., King, O. N. F., Passioura, T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14773 · Cited by 154
Self-citationSynthesis of Polyester by Means of Genetic Code Reprogramming
Ohta, A., Murakami, H., Higashimura, E., & Suga, H. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.015 · Cited by 153
Self-citationSICLOPPS cyclic peptide libraries in drug discovery
Tavassoli, A. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.02.016 · Cited by 150
Diverse backbone-cyclized peptides via codon reprogramming
Kawakami, T., Ohta, A., Ohuchi, M., Ashigai, H., Murakami, H., & Suga, H. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.259 · Cited by 142
Self-citationReevaluation of the D-amino acid compatibility with the elongation event in translation.
Fujino, T., Goto, Y., Suga, H., & Murakami, H. (2013) · Journal of the American Chemical Society · doi:10.1021/ja309570x · Cited by 133
Self-citationKatoh, T., Sengoku, T., Hirata, K., Ogata, K., & Suga, H. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0525-1 · Cited by 127
Self-citationEncoded libraries of chemically modified peptides
Heinis, C., & Winter, G. P. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.02.008 · Cited by 124
Artificial human Met agonists based on macrocycle scaffolds
Ito, K., Sakai, K., Suzuki, Y., Ozawa, N., Hatta, T., Natsume, T., Matsumoto, K., & Suga, H. (2015) · Nature Communications · doi:10.1038/ncomms7373 · Cited by 122
Self-citationRibosomal Synthesis of Peptides with Multiple β-Amino Acids.
Fujino, T., Goto, Y., Suga, H., & Murakami, H. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12482 · Cited by 120
Self-citationOwens, A. E., Iannuzzelli, J. A., Gu, Y., & Fasan, R. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b00927 · Cited by 120
Consecutive Elongation of D-Amino Acids in Translation
Katoh, T., Tajima, K., & Suga, H. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.11.012 · Cited by 119
Self-citationInitiating translation with D-amino acids.
Goto, Y., Murakami, H., & Suga, H. (2008) · RNA: A publication of the RNA Society · doi:10.1261/rna.1020708 · Cited by 114
Self-citationLogical engineering of D-arm and T-stem of tRNA that enhances d-amino acid incorporation
Katoh, T., Iwane, Y., & Suga, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1129 · Cited by 114
Self-citationIwane, Y., Hitomi, A., Murakami, H., Katoh, T., Goto, Y., & Suga, H. (2016) · Nature Chemistry · doi:10.1038/nchem.2446 · Cited by 112
Self-citationGoto, Y., Ito, Y., Kato, Y., Tsunoda, S., & Suga, H. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.04.008 · Cited by 110
Self-citationRibosomal Incorporation of Consecutive β-Amino Acids
Katoh, T., & Suga, H. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b07247 · Cited by 104
Self-citationExpanding the limits of the second genetic code with ribozymes
Lee, J., Schwieter, K. E., Watkins, A. M., Kim, D. S., Yu, H., Schwarz, K. J., Lim, J., Coronado, J. N., Byrom, M., Anslyn, E. V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12916-w · Cited by 101
Yamagata, K., Goto, Y., Nishimasu, H., Morimoto, J., Ishitani, R., Dohmae, N., Takeda, N., Nagai, R., Komuro, I., Suga, H., et al. (2014) · Structure · doi:10.1016/j.str.2013.12.001 · Cited by 99
Self-citationTranslation Initiation with Initiator tRNA Charged with Exotic Peptides
Goto, Y., & Suga, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900597d · Cited by 96
Self-citationEssential structural elements in tRNAPro for EF-P-mediated alleviation of translation stalling
Katoh, T., Wohlgemuth, I., Nagano, M., Rodnina, M. V., & Suga, H. (2016) · Nature Communications · doi:10.1038/ncomms11657 · Cited by 96
Self-citationRibosomal synthesis and folding of peptide-helical aromatic foldamer hybrids
Rogers, J. M., Kwon, S., Dawson, S. J., Mandal, P. K., Suga, H., & Huc, I. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0007-x · Cited by 96
Self-citationTargeting recognition surfaces on natural proteins with peptidic foldamers
Checco, J. W., & Gellman, S. H. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.06.014 · Cited by 88
Ribosome-mediated polymerization of long chain carbon and cyclic amino acids into peptides in vitro
Lee, J., Schwarz, K. J., Kim, D. S., Moore, J. S., & Jewett, M. C. (2020) · Nature Communications · doi:10.1038/s41467-020-18001-x · Cited by 88
Ozaki, T., Yamashita, K., Goto, Y., Shimomura, M., Hayashi, S., Asamizu, S., Sugai, Y., Ikeda, H., Suga, H., & Onaka, H. (2017) · Nature Communications · doi:10.1038/ncomms14207 · Cited by 87
Self-citationDe novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains
Nawatha, M., Rogers, J. M., Bonn, S. M., Livneh, I., Lemma, B. E., Mali, S. M., Vamisetti, G. B., Sun, H. H., Bercovich, B., Huang, Y., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0278-x · Cited by 85
Self-citationAllosteric Inhibition of a Semaphorin 4D Receptor Plexin B1 by a High-Affinity Macrocyclic Peptide
Matsunaga, Y., Bashiruddin, N. K., Kitago, Y., Takagi, J., & Suga, H. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.09.015 · Cited by 76
Self-citationMacrocyclic peptide-based inhibition and imaging of hepatocyte growth factor
Sakai, K., Passioura, T., Sato, H., Ito, K., Furuhashi, H., Umitsu, M., Takagi, J., Kato, Y., Mukai, H., Warashina, S., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0285-7 · Cited by 75
Self-citationRogers, J. M., & Suga, H. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01336d · Cited by 72
Self-citationMinimal lactazole scaffold for in vitro thiopeptide bioengineering
Vinogradov, A. A., Shimomura, M., Goto, Y., Ozaki, T., Asamizu, S., Sugai, Y., Suga, H., & Onaka, H. (2020) · Nature Communications · doi:10.1038/s41467-020-16145-4 · Cited by 71
Self-citationHazama, D., Yin, Y., Murata, Y., Matsuda, M., Okamoto, T., Tanaka, D., Terasaka, N., Zhao, J., Sakamoto, M., Kakuchi, Y., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.06.008 · Cited by 64
Self-citationTranslation of Diverse Aramid- and 1,3-Dicarbonyl-peptides by Wild Type Ribosomes in Vitro
Ad, O., Hoffman, K. S., Cairns, A. G., et al. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00460 · Cited by 61
Yu, H., Dranchak, P. K., Li, Z., MacArthur, R., Munson, M. S., Mehzabeen, N., Baird, N., Battaile, K. P., Ross, D., Lovell, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14932 · Cited by 54
Self-citationDe Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
Yin, Y., Ochi, N., Craven, T. W., Baker, D. A., Takigawa, N., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b09106 · Cited by 54
Self-citationRibosomal Formation of Thioamide Bonds in Polypeptide Synthesis
Maini, R., Kimura, H., Takatsuji, R., Katoh, T., Goto, Y., & Suga, H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11097 · Cited by 49
Self-citationKawakami, T., Ogawa, K., Hatta, T., Goshima, N., & Natsume, T. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01014 · Cited by 47
Synthesis and Screening of One-Bead-One-Compound Cyclic Peptide Libraries
Qian, Z., Upadhyaya, P., & Pei, D. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2020-4_3 · Cited by 45
Saito, M., Itoh, Y., Yasui, F., Munakata, T., Yamane, D., Ozawa, M., Ito, R., Katoh, T., Ishigaki, H., Nakayama, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22964-w · Cited by 43
Self-citationSakurai, Y., Mizumura, W., Murata, M., Hada, T., Yamamoto, S., Ito, K., Iwasaki, K., Katoh, T., Goto, Y., Takagi, A., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00362 · Cited by 40
Self-citationPromiscuous Enzymes Cooperate at the Substrate Level En Route to Lactazole A
Vinogradov, A. A., Shimomura, M., Kano, N., Goto, Y., Onaka, H., & Suga, H. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c05541 · Cited by 40
Self-citationSakurai, Y., Mizumura, W., Ito, K., Iwasaki, K., Katoh, T., Goto, Y., Suga, H., & Harashima, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00087 · Cited by 39
Self-citationNon-competitive cyclic peptides for targeting enzyme–substrate complexes
McAllister, T. E., Yeh, T., Abboud, M. I., Leung, I. K. H., Hookway, E. S., King, O. N. F., Bhushan, B., Williams, S. T., Hopkinson, R. J., Münzel, M., et al. (2018) · Chemical Science · doi:10.1039/c8sc00286j · Cited by 34
Self-citationIn vivo modulation of ubiquitin chains by N -methylated non-proteinogenic cyclic peptides
Rogers, J. M., Nawatha, M., Lemma, B. E., Vamisetti, G. B., Livneh, I., Barash, U., Vlodavsky, I., Ciechanover, A. J., Fushman, D., Suga, H., et al. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00179a · Cited by 33
Self-citationPosttranslational chemical installation of azoles into translated peptides
Tsutsumi, H., Kuroda, T., Kimura, H., Goto, Y., & Suga, H. (2021) · Nature Communications · doi:10.1038/s41467-021-20992-0 · Cited by 31
Self-citationVinogradov, A. A., Nagai, E., Chang, J. S., Narumi, K., Onaka, H., Goto, Y., & Suga, H. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c10374 · Cited by 30
Self-citationGoto, Y., & Suga, H. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.014 · Cited by 29
Self-citationRibosomal Incorporation of Aromatic Oligoamides as Peptide Sidechain Appendages
Tsiamantas, C., Kwon, S., Rogers, J. M., Douat, C., Huc, I., & Suga, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201914654 · Cited by 29
Self-citationBashiruddin, N. K., Hayashi, M., Nagano, M., Wu, Y. Z., Matsunaga, Y., Takagi, J., Nakashima, T., & Suga, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012266117 · Cited by 27
Self-citationLin, C., Harner, M. J., Douglas, A. E., Lafont, V., Yu, F., Lee, V. G., Poss, M. A., Swain, J. F., Wright, M. C., & Lipovšek, D. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202103043 · Cited by 27
Adaligil, E., Song, A., Hallenbeck, K. K., Cunningham, C. N., & Fairbrother, W. J. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00062 · Cited by 23
Bashiruddin, N. K., Matsunaga, Y., Nagano, M., Takagi, J., & Suga, H. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00219 · Cited by 19
Self-citationChemical Posttranslational Modification of Phage-Displayed Peptides
Ng, S., Tjhung, K. F., Paschal, B. M., Noren, C. J., & Derda, R. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2020-4_11 · Cited by 18
Nonstandard Peptide Expression under the Genetic Code Consisting of Reprogrammed Dual Sense Codons
Goto, Y., Iseki, M., Hitomi, A., Murakami, H., & Suga, H. (2013) · ACS Chemical Biology · doi:10.1021/cb400549p · Cited by 17
Self-citationIn Vitro Biosynthesis of Peptides Containing Exotic Azoline Analogues
Goto, Y., & Suga, H. (2019) · ChemBioChem · doi:10.1002/cbic.201900521 · Cited by 17
Self-citationGoto, Y., & Suga, H. (2016) · Chemistry Letters · doi:10.1246/cl.160562 · Cited by 13
Self-citationKato, Y., Kuroda, T., Huang, Y., Ohta, R., Goto, Y., & Suga, H. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201910894 · Cited by 13
Self-citationArtificial In Vitro Biosynthesis Systems for the Development of Pseudo-Natural Products
Goto, Y., & Suga, H. (2018) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20170379 · Cited by 9
Self-citation
Cited by
Cyclic Peptides for Drug Development
Ji, X., Nielsen, A. L., & Heinis, C. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202308251 · Cited by 411
Design of Cyclic Peptides Targeting Protein–Protein Interactions Using AlphaFold
(2023) · doi:10.3390/ijms241713257 · Cited by 51
Facilitating the structural characterisation of non-canonical amino acids in biomolecular NMR
Kuschert, S., Stroet, M., Chin, Y. K.-Y., Conibear, A. C., Jia, X., Lee, T., Bartling, C. R. O., Strømgaard, K., Güntert, P., Rosengren, K. J., et al. (2023) · Magnetic Resonance · doi:10.5194/mr-4-57-2023 · Cited by 9
De novo design of a fusion protein tool for GPCR research
(2025) · doi:10.1073/pnas.2422360122 · Cited by 8
Development and structure-guided characterization of a novel ACE2-binding macrocyclic peptide
Benoit, R. M., Wang, J., Beyer, D., Abbas, A., Rodrigues, M. J., Wieser, M. M., Deupi, X., Müller, C., Suga, H., & Bode, J. W. (2026) · Journal of Structural Biology: X · doi:10.1016/j.yjsbx.2026.100145
“With the ultimate aim to develop novel ACE2 radiotracers, we utilized the “ Random non-standard Peptides Integrated Discovery ” (RaPID) platform (Goto and Suga, 2021) to generate a macrocyclic peptide, WJL-63, that specifically binds to ACE2.”
Self-citation
Metadata
- Authors
- Goto, Y., & Suga, H.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-09-10
- Volume
- 54
- Issue
- 18
- Pages
- 3604-3617
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W3196622003
- Cited by
- 262
- References
- 76
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.